BioCentury | Mar 23, 2009
Company News

CG Therapeutics management update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Promoted: Denise Harrison to president and CEO from CFO; she replaces Jonathan Green WIR Staff cancer...
BioCentury | Apr 7, 2008
Company News

CG Therapeutics, University of Washington deal

...that is in Phase II testing to treat solid tumors. Financial terms were not disclosed. CG Therapeutics Inc....
BioCentury | Mar 10, 2008
Emerging Company Profile

Corporate Profile

...Corporate Profile CG Therapeutics Inc. Seattle, Wash. Technology: Vaccines and mAbs Disease focus: Cancer Clinical status: Phase II...
BioCentury | Mar 10, 2008
Emerging Company Profile

CG Therapeutics: Hormone neutralizer

...While most cancer vaccines aim to stimulate the immune system to boost T cell production, CG Therapeutics Inc....
...seeking partners for further testing. COMPANIES AND INSTITUTIONS MENTIONED AVI Biopharma Inc. (NASDAQ:AVII), Portland, Ore. CG Therapeutics Inc....
BioCentury | Sep 24, 2007
Company News

CG Therapeutics board of directors update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Appointed: Christopher Henney, chairman of Biomira Inc. and SGX Pharmaceuticals Inc. , as chairman WIR Staff cancer...
Items per page:
1 - 5 of 5
BioCentury | Mar 23, 2009
Company News

CG Therapeutics management update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Promoted: Denise Harrison to president and CEO from CFO; she replaces Jonathan Green WIR Staff cancer...
BioCentury | Apr 7, 2008
Company News

CG Therapeutics, University of Washington deal

...that is in Phase II testing to treat solid tumors. Financial terms were not disclosed. CG Therapeutics Inc....
BioCentury | Mar 10, 2008
Emerging Company Profile

Corporate Profile

...Corporate Profile CG Therapeutics Inc. Seattle, Wash. Technology: Vaccines and mAbs Disease focus: Cancer Clinical status: Phase II...
BioCentury | Mar 10, 2008
Emerging Company Profile

CG Therapeutics: Hormone neutralizer

...While most cancer vaccines aim to stimulate the immune system to boost T cell production, CG Therapeutics Inc....
...seeking partners for further testing. COMPANIES AND INSTITUTIONS MENTIONED AVI Biopharma Inc. (NASDAQ:AVII), Portland, Ore. CG Therapeutics Inc....
BioCentury | Sep 24, 2007
Company News

CG Therapeutics board of directors update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Appointed: Christopher Henney, chairman of Biomira Inc. and SGX Pharmaceuticals Inc. , as chairman WIR Staff cancer...
Items per page:
1 - 5 of 5